{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T11:50:03Z","timestamp":1792497003567,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"vor","delay-in-days":1461,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.kint.2016.09.022","type":"journal-article","created":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T08:16:17Z","timestamp":1480580177000},"page":"603-615","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"title":["IL-2\/anti-IL-2 complexes ameliorate lupus nephritis by expansion of CD4+CD25+Foxp3+ regulatory T\u00a0cells"],"prefix":"10.1016","volume":"91","author":[{"given":"Ji-Jing","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Ghi","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joon Young","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tai Yeon","family":"Koo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Curie","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaeseok","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2016.09.022_bib1","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1136\/jcp.56.7.481","article-title":"Pathogenesis of systemic lupus erythematosus","volume":"56","author":"Mok","year":"2003","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.kint.2016.09.022_bib2","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1056\/NEJMra1100359","article-title":"Systemic lupus erythematosus","volume":"365","author":"Tsokos","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2016.09.022_bib3","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nrneph.2014.215","article-title":"Treatment of severe lupus nephritis: the new horizon","volume":"11","author":"Chan","year":"2015","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.kint.2016.09.022_bib4","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1136\/ard.2008.092163","article-title":"Dose-related patterns of glucocorticoid-induced side effects","volume":"68","author":"Huscher","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.kint.2016.09.022_bib5","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1177\/096120339500400103","article-title":"Ovarian failure in oral cyclophosphamide treatment for systemic lupus erythematosus","volume":"4","author":"Wang","year":"1995","journal-title":"Lupus"},{"key":"10.1016\/j.kint.2016.09.022_bib6","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1136\/ard.55.4.224","article-title":"Incidence of ovarian failure in systemic lupus erythematosus after treatment with pulse cyclophosphamide","volume":"55","author":"McDermott","year":"1996","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.kint.2016.09.022_bib7","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1126\/science.1142331","article-title":"Emerging Challenges in Regulatory T Cell Function and Biology","volume":"317","author":"Sakaguchi","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.kint.2016.09.022_bib8","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1093\/intimm\/dxn044","article-title":"Quantitative and qualitative deficiencies of regulatory T cells in patients with systemic lupus erythematosus (SLE)","volume":"20","author":"Bonelli","year":"2008","journal-title":"Int Immunol"},{"key":"10.1016\/j.kint.2016.09.022_bib9","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nrrheum.2010.60","article-title":"T\u00a0cells as therapeutic targets in SLE","volume":"6","author":"Crispin","year":"2010","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.kint.2016.09.022_bib10","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1146\/annurev.immunol.18.1.423","article-title":"Regulatory T cells in autoimmmunity","volume":"18","author":"Shevach","year":"2000","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.kint.2016.09.022_bib11","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0896-8411(03)00121-5","article-title":"Quantification of regulatory T cells in patients with systemic lupus erythematosus","volume":"21","author":"Crispin","year":"2003","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.kint.2016.09.022_bib12","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/978-0-387-72005-0_12","article-title":"Reduced number and\u00a0function of CD4+CD25highFoxP3+ regulatory T cells in patients with systemic lupus erythematosus","volume":"601","author":"Lyssuk","year":"2007","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.kint.2016.09.022_bib13","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.4049\/jimmunol.155.3.1151","article-title":"Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases","volume":"155","author":"Sakaguchi","year":"1995","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.kint.2016.09.022_bib14","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1038\/ni1263","article-title":"A\u00a0function for interleukin 2 in Foxp3-expressing regulatory T cells","volume":"6","author":"Fontenot","year":"2005","journal-title":"Nat Immunol"},{"key":"10.1016\/j.kint.2016.09.022_bib15","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1136\/ard.2007.083543","article-title":"Clinical significance of increased CD4+CD25-Foxp3+ T cells in patients with new-onset systemic lupus erythematosus","volume":"67","author":"Zhang","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.kint.2016.09.022_bib16","doi-asserted-by":"crossref","first-page":"R153","DOI":"10.1186\/ar2829","article-title":"Are CD4+CD25-Foxp3+ cells in untreated new-onset lupus patients regulatory T cells?","volume":"11","author":"Yang","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.kint.2016.09.022_bib17","doi-asserted-by":"crossref","first-page":"R104","DOI":"10.1186\/ar4553","article-title":"CD4(+)CD25(-)Foxp3(+) T cells: a marker for lupus nephritis?","volume":"16","author":"Bonelli","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.kint.2016.09.022_bib18","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1136\/ard.2007.083543","article-title":"Clinical significance of increased CD4+CD25\u2212Foxp3+ T cells in patients with new-onset systemic lupus erythematosus","volume":"67","author":"Zhang","year":"2008","journal-title":"Ann Rheum Di"},{"key":"10.1016\/j.kint.2016.09.022_bib19","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1084\/jem.154.5.1671","article-title":"Deficient interleukin 2 activity in MRL\/Mp and C57BL\/6J mice bearing the lpr gene","volume":"154","author":"Wofsy","year":"1981","journal-title":"J\u00a0Expe Med"},{"key":"10.1016\/j.kint.2016.09.022_bib20","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.autrev.2009.02.035","article-title":"Interleukin 2 and systemic lupus erythematosus: Beyond the transcriptional regulatory net abnormalities","volume":"9","author":"G\u00f3mez-Mart\u00edn","year":"2009","journal-title":"Autoimmu Rev"},{"key":"10.1016\/j.kint.2016.09.022_bib21","doi-asserted-by":"crossref","first-page":"R35","DOI":"10.1186\/ar4188","article-title":"CD4+Foxp3+ regulatory T cells prolong drug-induced disease remission in (NZBxNZW) F1 lupus mice","volume":"15","author":"Weigert","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.kint.2016.09.022_bib22","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1126\/science.1122927","article-title":"Selective stimulation of T cell subsets with antibody-cytokine immune complexes","volume":"311","author":"Boyman","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.kint.2016.09.022_bib23","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1084\/jem.20082824","article-title":"In\u00a0vivo expansion of T reg cells with IL-2\u2013mAb complexes: induction of resistance to EAE and long-term acceptance of islet\u00a0allografts without immunosuppression","volume":"206","author":"Webster","year":"2009","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.kint.2016.09.022_bib24","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1681\/ASN.2011111130","article-title":"IL-2\/IL-2Ab Complexes Induce Regulatory T Cell Expansion and Protect against Proteinuric CKD","volume":"23","author":"Polhill","year":"2012","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2016.09.022_bib25","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1681\/ASN.2012080784","article-title":"IL-2\/Anti-IL-2 Complex Attenuates Renal Ischemia-Reperfusion Injury through Expansion of Regulatory T Cells","volume":"24","author":"Kim","year":"2013","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2016.09.022_bib26","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0065-2776(08)60342-9","article-title":"Murine models of systemic lupus erythematosus","volume":"37","author":"Theofilopoulos","year":"1985","journal-title":"Adv Immunol"},{"key":"10.1016\/j.kint.2016.09.022_bib27","first-page":"980286","article-title":"Th subset balance in lupus nephritis","volume":"2011","author":"Miyake","year":"2011","journal-title":"J\u00a0Biomed Biotechnol"},{"key":"10.1016\/j.kint.2016.09.022_bib28","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/art.38955","article-title":"Function of the Th17\/interleukin-17A immune response in murine lupus nephritis","volume":"67","author":"Schmidt","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.kint.2016.09.022_bib29","first-page":"131","article-title":"Follicular helper T cells: new insights into mechanisms of autoimmune diseases","volume":"13","author":"Zhang","year":"2013","journal-title":"Ochsner J"},{"key":"10.1016\/j.kint.2016.09.022_bib30","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a015552","article-title":"Regulatory T-cell therapy in transplantation: moving to the clinic","volume":"3","author":"Tang","year":"2013","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.kint.2016.09.022_bib31","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.trim.2012.05.001","article-title":"Immunosuppressive drugs on inducing Ag-specific CD4(+)CD25(+)Foxp3(+) Treg cells during immune response in\u00a0vivo","volume":"27","author":"Wu","year":"2012","journal-title":"Transpl Immunol"},{"key":"10.1016\/j.kint.2016.09.022_bib32","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.trim.2010.04.002","article-title":"Mycophenolate mofetil modifies kidney tubular injury and Foxp3+ regulatory T cell trafficking during recovery from experimental ischemia-reperfusion","volume":"23","author":"Gandolfo","year":"2010","journal-title":"Transpl Immunol"},{"key":"10.1016\/j.kint.2016.09.022_bib33","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1097\/TP.0b013e3181d3c9d4","article-title":"Impact of immunosuppressants on the therapeutic efficacy of in\u00a0vitro-expanded CD4+CD25+Foxp3+ regulatory T cells in allotransplantation","volume":"89","author":"Lim","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.kint.2016.09.022_bib34","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.2215\/CJN.03180509","article-title":"Immunosuppressive drugs and Tregs: a critical evaluation!","volume":"4","author":"De Serres","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2016.09.022_bib35","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.clim.2008.01.011","article-title":"Rituximab-induced B cell depletion in autoimmune diseases: potential effects on T cells","volume":"127","author":"Liossis","year":"2008","journal-title":"Clin Immunol"},{"key":"10.1016\/j.kint.2016.09.022_bib36","doi-asserted-by":"crossref","first-page":"7018","DOI":"10.1073\/pnas.0602311103","article-title":"Immune dysregulation accelerates atherosclerosis and modulates plaque composition in systemic lupus erythematosus","volume":"103","author":"Stanic","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.kint.2016.09.022_bib37","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/ki.2010.438","article-title":"Targeting transcription factor Stat4 uncovers a role for interleukin-18 in the pathogenesis of severe lupus nephritis in mice","volume":"79","author":"Menke","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2016.09.022_bib38","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.4049\/jimmunol.177.5.3380","article-title":"Phenotypic and functional characterization of kidney-infiltrating lymphocytes in renal ischemia reperfusion injury","volume":"177","author":"Ascon","year":"2006","journal-title":"J\u00a0Immunol"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253816305518?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253816305518?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T04:10:40Z","timestamp":1692591040000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253816305518"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S0085253816305518"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2016.09.022","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IL-2\/anti-IL-2 complexes ameliorate lupus nephritis by expansion of CD4+CD25+Foxp3+ regulatory T\u00a0cells","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2016.09.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016, International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}